| 发明名称 |
Medicament for treating a manifested lyme disease |
| 摘要 |
A pharmaceutical composition for treating Lyme disease contains an antibody as an active agent which is specific for the 24 kDa antigen (OspC) of B. burgdorferi, preferably an antibody which is specific for the 24 kDa antigen (OspC) of B. burgdorferi having the sequence shown in SEQ ID NO.2.
|
| 申请公布号 |
US6761891(B1) |
申请公布日期 |
2004.07.13 |
| 申请号 |
US20000508096 |
申请日期 |
2000.07.06 |
| 申请人 |
MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. |
发明人 |
SIMON MARKUS M.;ZHONG WEIMIN;WALLICH REINHARD;KRAMER MICHAEL D. |
| 分类号 |
A61K38/00;A61K39/00;C07K14/20;C07K16/12;C12N15/31;(IPC1-7):A61K39/02;A61K49/00;A61K39/395;A61K39/40;A61K39/38 |
主分类号 |
A61K38/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
